XML 26 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share-Based Awards
6 Months Ended
Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Awards
Share-Based Awards
Employee Stock Option and Incentive Plans
In October 2005, our shareholders approved a stock option and incentive plan (the “2005 Plan”) under which 4,800,000 shares of common stock were reserved for the issuance of awards, including incentive stock options and non-qualified stock options, stock appreciation rights, restricted stock, unrestricted stock, restricted stock units, performance shares, performance units (including performance options) and other share-based awards. The 2005 Plan provides that our employees and directors may, at the discretion of the Board of Directors or a duly designated compensation committee, be granted certain share-based awards. In the case of option awards granted under the 2005 Plan, the exercise price of each option is determined based on the date of grant and expire no later than 10 years from the date of grant. Awards granted pursuant to the 2005 Plan are subject to the vesting schedule or performance metrics set forth in the agreements pursuant to which they are granted. Upon a change of control of our Company, as such term is defined in the 2005 Plan, awards under the 2005 Plan will fully vest under certain circumstances. The 2005 Plan expired on May 25, 2015. As of September 30, 2016, there were 1,186,101 outstanding options and 567 outstanding shares of restricted stock, restricted stock units and performance based restricted stock under the 2005 Plan.
In August 2015, our shareholders approved a stock option and incentive plan (the “2015 Plan”) under which 11,500,000 shares of common stock were reserved for the issuance of awards, including incentive stock options and non-qualified stock options, stock appreciation rights, restricted stock awards and restricted stock unit awards, performance stock awards and other share-based awards. The 2015 Plan provides that our employees and directors may, at the discretion of the Board of Directors or a duly designated compensation committee, be granted certain share-based awards. In the case of option awards granted under the 2015 Plan, the exercise price of each option is determined based on the date of grant and expire no later than 10 years from the date of grant. Awards granted pursuant to the 2015 Plan are subject to the vesting schedule or performance metrics set forth in the agreements pursuant to which they are granted. Upon a change of control of our Company, as such term is defined in the 2015 Plan, awards under the 2015 Plan will fully vest under certain circumstances. As of September 30, 2016, there were 1,993,250 outstanding options, 723,233 outstanding shares of restricted stock awards and 8,389,780 shares available for future grant under the 2015 Plan.
A summary of stock option transactions during the six months ended September 30, 2016 follows:
 
 
Number of
Shares
 
Weighted-
Average
Exercise
Price
per Share
 
Weighted-
Average
Remaining
Contractual
Life (years)
 
Aggregate
Intrinsic
Value
(in thousands)
Outstanding, April 1, 2016
 
2,447,286

 
$
19.55

 
6.3
 
$
574

Granted
 
1,006,500

 
12.83

 
7.7
 
 
Forfeited/Canceled
 
(274,435
)
 
20.51

 
1.5
 


Outstanding, September 30, 2016
 
3,179,351

 
$
17.34

 
6.4
 
$

Vested and expected to vest, September 30, 2016
 
2,882,425

 
$
17.61

 
6.4
 
$

Exercisable, September 30, 2016
 
757,466

 
$
25.89

 
4.1
 
$



We utilize the Black-Scholes valuation model for estimating the fair value of share-based compensation with the following assumptions:
 
Three Months Ended September 30,
 
Six Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
Expected term
6.6 years
 
3.9 years
 
6.0 - 6.6 years
 
3.8 - 3.9 years
Expected volatility
36.9%
 
38.9%
 
36.9% - 37.4%
 
38.3% - 38.9%
Expected dividends
—%
 
5.3%
 
—%
 
4.1% - 5.3%
Risk-free rate
1.2%
 
1.3%
 
1.2% - 1.5%
 
1.3% - 1.6%

The weighted-average grant date fair value of stock options granted during the six months ended September 30, 2016 and 2015 was $4.92 and $3.36 per share, respectively.
During the six months ended September 30, 2016, a total of 1,006,500 options to purchase shares of common stock were granted under the 2015 Plan at an exercise price equal to the market price of our common stock on the date of grant, as summarized below:
Option Grant Date
 
Number of Shares
 
Exercise Price
 
Vesting Terms (1)
 
Expiration
May 31, 2016
 
100,000

 
$
12.71

 
Five years
 
May 31, 2024
May 25, 2016
 
216,500

 
$
12.78

 
Four years
 
May 25, 2024
May 24, 2016
 
540,000

 
$
12.93

 
Four years
 
May 24, 2024
July 11, 2016
 
150,000

 
$
12.60

 
Four years
 
July 11, 2024
Fiscal year 2017 grants
 
1,006,500

 
 
 
 
 
 
__________________________________
(1) Options vest in equal annual installments on each grant anniversary date commencing one year following the date of grant.
Non-vested stock option award activity during the six months ended September 30, 2016 is summarized as follows:
 
 
Non-Vested
Number of
Shares
 
Weighted-
Average
Grant-Date
Fair Value
per Share
Outstanding, April 1, 2016
 
1,859,750

 
$
4.67

Granted
 
993,250

 
4.92

Vested
 
(275,595
)
 
5.39

Forfeited/Canceled
 
(168,770
)
 
4.37

Outstanding, September 30, 2016
 
2,408,635

 
$
4.71


As of September 30, 2016, $9,635 of total unrecognized compensation costs related to stock options is expected to be recognized over a weighted-average period of 3.8 years. This amount does not include the cost of new options that may be granted in future periods or any changes in our forfeiture percentage. The total fair value of options vested during the six months ended September 30, 2016 and 2015 was $1,486 and $1,735, respectively.
Employee Share Purchase Plan
On August 11, 2014, our shareholders approved an Employee Share Purchase Plan (the “Purchase Plan”) under which 4,000,000 shares of common stock were reserved for future grant.  The Purchase Plan allows eligible employees to purchase shares through payroll deductions of up to 15% of total base salary at a price equal to 90% of the lower of the fair market values of the shares as of the beginning or the end of the corresponding offering period.  Any shares purchased under the Purchase Plan are subject to a six-month holding period.  Employees are limited to purchasing no more than 1,500 shares on any single purchase date and no more than $25,000 in total fair market value of shares during any one calendar year. As of September 30, 2016, we have issued 181,203 shares under the Purchase Plan and 3,818,797 shares are available for future issuance.
Share-based compensation expense recorded for the employee share purchase plan was $81 and $78 for the three months ended September 30, 2016 and 2015, respectively. Share-based compensation expense recorded for the employee share purchase plan was $207 and $146 for the six months ended September 30, 2016 and 2015, respectively.
Restricted Stock Awards
Restricted stock awards activity during the three and six months ended September 30, 2016 is summarized as follows:
 
 
Number of
Shares
 
Weighted-
Average
Grant-Date
Fair Value
per Share
Outstanding, April 1, 2016
 
191,247

 
$
14.44

Granted
 
619,874

 
12.68

Vested
 
(68,309
)
 
14.17

Canceled
 
(19,012
)
 
12.78

Outstanding, September 30, 2016
 
723,800

 
$
12.99

Share-based compensation expense related to restricted stock awards was $972 and $217 for the three months ended September 30, 2016 and 2015, respectively. Share-based compensation expense related to restricted stock awards was $1,517 and $415 for the six months ended September 30, 2016 and 2015, respectively.
The weighted-average grant date fair value for the restricted stock awards was estimated using the market price of the common stock on the date of grant. The fair value of the restricted stock awards is amortized on a straight-line basis over the vesting period.
As of September 30, 2016, $8,217 of total unrecognized compensation costs related to restricted stock awards is expected to be recognized over a weighted-average period of 2.2 years. This amount does not include the cost of new restricted stock awards that may be granted in future periods.